Global Recombinant Human Chorionic Gonadotropin Supply, Demand and Key Producers, 2023-2029
The global Recombinant Human Chorionic Gonadotropin market size is expected to reach $ million by 2029, rising at a market growth of % CAGR during the forecast period (2023-2029).
This report studies the global Recombinant Human Chorionic Gonadotropin production, demand, key manufacturers, and key regions.
This report is a detailed and comprehensive analysis of the world market for Recombinant Human Chorionic Gonadotropin, and provides market size (US$ million) and Year-over-Year (YoY) Growth, considering 2022 as the base year. This report explores demand trends and competition, as well as details the characteristics of Recombinant Human Chorionic Gonadotropin that contribute to its increasing demand across many markets.
Highlights and key features of the study
Global Recombinant Human Chorionic Gonadotropin total production and demand, 2018-2029, (K Units)
Global Recombinant Human Chorionic Gonadotropin total production value, 2018-2029, (USD Million)
Global Recombinant Human Chorionic Gonadotropin production by region & country, production, value, CAGR, 2018-2029, (USD Million) & (K Units)
Global Recombinant Human Chorionic Gonadotropin consumption by region & country, CAGR, 2018-2029 & (K Units)
U.S. VS China: Recombinant Human Chorionic Gonadotropin domestic production, consumption, key domestic manufacturers and share
Global Recombinant Human Chorionic Gonadotropin production by manufacturer, production, price, value and market share 2018-2023, (USD Million) & (K Units)
Global Recombinant Human Chorionic Gonadotropin production by Type, production, value, CAGR, 2018-2029, (USD Million) & (K Units)
Global Recombinant Human Chorionic Gonadotropin production by Application production, value, CAGR, 2018-2029, (USD Million) & (K Units)
This reports profiles key players in the global Recombinant Human Chorionic Gonadotropin market based on the following parameters – company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Ferring Pharmaceuticals, Schering Plough, Serum International Ltd, Merck, Wellona Pharma, Bionomics Lifesciences, Marvel Oceanic Private Limited and Facmed Pharmaceuticals, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Recombinant Human Chorionic Gonadotropin market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), volume (production, consumption) & (K Units) and average price (US$/Unit) by manufacturer, by Type, and by Application. Data is given for the years 2018-2029 by year with 2022 as the base year, 2023 as the estimate year, and 2024-2029 as the forecast year.
Global Recombinant Human Chorionic Gonadotropin Market, By Region:
1. How big is the global Recombinant Human Chorionic Gonadotropin market?
2. What is the demand of the global Recombinant Human Chorionic Gonadotropin market?
3. What is the year over year growth of the global Recombinant Human Chorionic Gonadotropin market?
4. What is the production and production value of the global Recombinant Human Chorionic Gonadotropin market?
5. Who are the key producers in the global Recombinant Human Chorionic Gonadotropin market?
6. What are the growth factors driving the market demand?
This report studies the global Recombinant Human Chorionic Gonadotropin production, demand, key manufacturers, and key regions.
This report is a detailed and comprehensive analysis of the world market for Recombinant Human Chorionic Gonadotropin, and provides market size (US$ million) and Year-over-Year (YoY) Growth, considering 2022 as the base year. This report explores demand trends and competition, as well as details the characteristics of Recombinant Human Chorionic Gonadotropin that contribute to its increasing demand across many markets.
Highlights and key features of the study
Global Recombinant Human Chorionic Gonadotropin total production and demand, 2018-2029, (K Units)
Global Recombinant Human Chorionic Gonadotropin total production value, 2018-2029, (USD Million)
Global Recombinant Human Chorionic Gonadotropin production by region & country, production, value, CAGR, 2018-2029, (USD Million) & (K Units)
Global Recombinant Human Chorionic Gonadotropin consumption by region & country, CAGR, 2018-2029 & (K Units)
U.S. VS China: Recombinant Human Chorionic Gonadotropin domestic production, consumption, key domestic manufacturers and share
Global Recombinant Human Chorionic Gonadotropin production by manufacturer, production, price, value and market share 2018-2023, (USD Million) & (K Units)
Global Recombinant Human Chorionic Gonadotropin production by Type, production, value, CAGR, 2018-2029, (USD Million) & (K Units)
Global Recombinant Human Chorionic Gonadotropin production by Application production, value, CAGR, 2018-2029, (USD Million) & (K Units)
This reports profiles key players in the global Recombinant Human Chorionic Gonadotropin market based on the following parameters – company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Ferring Pharmaceuticals, Schering Plough, Serum International Ltd, Merck, Wellona Pharma, Bionomics Lifesciences, Marvel Oceanic Private Limited and Facmed Pharmaceuticals, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Recombinant Human Chorionic Gonadotropin market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), volume (production, consumption) & (K Units) and average price (US$/Unit) by manufacturer, by Type, and by Application. Data is given for the years 2018-2029 by year with 2022 as the base year, 2023 as the estimate year, and 2024-2029 as the forecast year.
Global Recombinant Human Chorionic Gonadotropin Market, By Region:
- United States
- China
- Europe
- Japan
- South Korea
- ASEAN
- India
- Rest of World
- Intramuscular Powder for Injection
- Subcutaneous Solution for Injection
- Female
- Male
- Ferring Pharmaceuticals
- Schering Plough
- Serum International Ltd
- Merck
- Wellona Pharma
- Bionomics Lifesciences
- Marvel Oceanic Private Limited
- Facmed Pharmaceuticals
1. How big is the global Recombinant Human Chorionic Gonadotropin market?
2. What is the demand of the global Recombinant Human Chorionic Gonadotropin market?
3. What is the year over year growth of the global Recombinant Human Chorionic Gonadotropin market?
4. What is the production and production value of the global Recombinant Human Chorionic Gonadotropin market?
5. Who are the key producers in the global Recombinant Human Chorionic Gonadotropin market?
6. What are the growth factors driving the market demand?
1 SUPPLY SUMMARY
1.1 Recombinant Human Chorionic Gonadotropin Introduction
1.2 World Recombinant Human Chorionic Gonadotropin Supply & Forecast
1.2.1 World Recombinant Human Chorionic Gonadotropin Production Value (2018 & 2022 & 2029)
1.2.2 World Recombinant Human Chorionic Gonadotropin Production (2018-2029)
1.2.3 World Recombinant Human Chorionic Gonadotropin Pricing Trends (2018-2029)
1.3 World Recombinant Human Chorionic Gonadotropin Production by Region (Based on Production Site)
1.3.1 World Recombinant Human Chorionic Gonadotropin Production Value by Region (2018-2029)
1.3.2 World Recombinant Human Chorionic Gonadotropin Production by Region (2018-2029)
1.3.3 World Recombinant Human Chorionic Gonadotropin Average Price by Region (2018-2029)
1.3.4 North America Recombinant Human Chorionic Gonadotropin Production (2018-2029)
1.3.5 Europe Recombinant Human Chorionic Gonadotropin Production (2018-2029)
1.3.6 China Recombinant Human Chorionic Gonadotropin Production (2018-2029)
1.3.7 Japan Recombinant Human Chorionic Gonadotropin Production (2018-2029)
1.4 Market Drivers, Restraints and Trends
1.4.1 Recombinant Human Chorionic Gonadotropin Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 Recombinant Human Chorionic Gonadotropin Major Market Trends
1.5 Influence of COVID-19 and Russia-Ukraine War
1.5.1 Influence of COVID-19
1.5.2 Influence of Russia-Ukraine War
2 DEMAND SUMMARY
2.1 World Recombinant Human Chorionic Gonadotropin Demand (2018-2029)
2.2 World Recombinant Human Chorionic Gonadotropin Consumption by Region
2.2.1 World Recombinant Human Chorionic Gonadotropin Consumption by Region (2018-2023)
2.2.2 World Recombinant Human Chorionic Gonadotropin Consumption Forecast by Region (2024-2029)
2.3 United States Recombinant Human Chorionic Gonadotropin Consumption (2018-2029)
2.4 China Recombinant Human Chorionic Gonadotropin Consumption (2018-2029)
2.5 Europe Recombinant Human Chorionic Gonadotropin Consumption (2018-2029)
2.6 Japan Recombinant Human Chorionic Gonadotropin Consumption (2018-2029)
2.7 South Korea Recombinant Human Chorionic Gonadotropin Consumption (2018-2029)
2.8 ASEAN Recombinant Human Chorionic Gonadotropin Consumption (2018-2029)
2.9 India Recombinant Human Chorionic Gonadotropin Consumption (2018-2029)
3 WORLD RECOMBINANT HUMAN CHORIONIC GONADOTROPIN MANUFACTURERS COMPETITIVE ANALYSIS
3.1 World Recombinant Human Chorionic Gonadotropin Production Value by Manufacturer (2018-2023)
3.2 World Recombinant Human Chorionic Gonadotropin Production by Manufacturer (2018-2023)
3.3 World Recombinant Human Chorionic Gonadotropin Average Price by Manufacturer (2018-2023)
3.4 Recombinant Human Chorionic Gonadotropin Company Evaluation Quadrant
3.5 Industry Rank and Concentration Rate (CR)
3.5.1 Global Recombinant Human Chorionic Gonadotropin Industry Rank of Major Manufacturers
3.5.2 Global Concentration Ratios (CR4) for Recombinant Human Chorionic Gonadotropin in 2022
3.5.3 Global Concentration Ratios (CR8) for Recombinant Human Chorionic Gonadotropin in 2022
3.6 Recombinant Human Chorionic Gonadotropin Market: Overall Company Footprint Analysis
3.6.1 Recombinant Human Chorionic Gonadotropin Market: Region Footprint
3.6.2 Recombinant Human Chorionic Gonadotropin Market: Company Product Type Footprint
3.6.3 Recombinant Human Chorionic Gonadotropin Market: Company Product Application Footprint
3.7 Competitive Environment
3.7.1 Historical Structure of the Industry
3.7.2 Barriers of Market Entry
3.7.3 Factors of Competition
3.8 New Entrant and Capacity Expansion Plans
3.9 Mergers, Acquisition, Agreements, and Collaborations
4 UNITED STATES VS CHINA VS REST OF THE WORLD
4.1 United States VS China: Recombinant Human Chorionic Gonadotropin Production Value Comparison
4.1.1 United States VS China: Recombinant Human Chorionic Gonadotropin Production Value Comparison (2018 & 2022 & 2029)
4.1.2 United States VS China: Recombinant Human Chorionic Gonadotropin Production Value Market Share Comparison (2018 & 2022 & 2029)
4.2 United States VS China: Recombinant Human Chorionic Gonadotropin Production Comparison
4.2.1 United States VS China: Recombinant Human Chorionic Gonadotropin Production Comparison (2018 & 2022 & 2029)
4.2.2 United States VS China: Recombinant Human Chorionic Gonadotropin Production Market Share Comparison (2018 & 2022 & 2029)
4.3 United States VS China: Recombinant Human Chorionic Gonadotropin Consumption Comparison
4.3.1 United States VS China: Recombinant Human Chorionic Gonadotropin Consumption Comparison (2018 & 2022 & 2029)
4.3.2 United States VS China: Recombinant Human Chorionic Gonadotropin Consumption Market Share Comparison (2018 & 2022 & 2029)
4.4 United States Based Recombinant Human Chorionic Gonadotropin Manufacturers and Market Share, 2018-2023
4.4.1 United States Based Recombinant Human Chorionic Gonadotropin Manufacturers, Headquarters and Production Site (States, Country)
4.4.2 United States Based Manufacturers Recombinant Human Chorionic Gonadotropin Production Value (2018-2023)
4.4.3 United States Based Manufacturers Recombinant Human Chorionic Gonadotropin Production (2018-2023)
4.5 China Based Recombinant Human Chorionic Gonadotropin Manufacturers and Market Share
4.5.1 China Based Recombinant Human Chorionic Gonadotropin Manufacturers, Headquarters and Production Site (Province, Country)
4.5.2 China Based Manufacturers Recombinant Human Chorionic Gonadotropin Production Value (2018-2023)
4.5.3 China Based Manufacturers Recombinant Human Chorionic Gonadotropin Production (2018-2023)
4.6 Rest of World Based Recombinant Human Chorionic Gonadotropin Manufacturers and Market Share, 2018-2023
4.6.1 Rest of World Based Recombinant Human Chorionic Gonadotropin Manufacturers, Headquarters and Production Site (State, Country)
4.6.2 Rest of World Based Manufacturers Recombinant Human Chorionic Gonadotropin Production Value (2018-2023)
4.6.3 Rest of World Based Manufacturers Recombinant Human Chorionic Gonadotropin Production (2018-2023)
5 MARKET ANALYSIS BY TYPE
5.1 World Recombinant Human Chorionic Gonadotropin Market Size Overview by Type: 2018 VS 2022 VS 2029
5.2 Segment Introduction by Type
5.2.1 Intramuscular Powder for Injection
5.2.2 Subcutaneous Solution for Injection
5.3 Market Segment by Type
5.3.1 World Recombinant Human Chorionic Gonadotropin Production by Type (2018-2029)
5.3.2 World Recombinant Human Chorionic Gonadotropin Production Value by Type (2018-2029)
5.3.3 World Recombinant Human Chorionic Gonadotropin Average Price by Type (2018-2029)
6 MARKET ANALYSIS BY APPLICATION
6.1 World Recombinant Human Chorionic Gonadotropin Market Size Overview by Application: 2018 VS 2022 VS 2029
6.2 Segment Introduction by Application
6.2.1 Female
6.2.2 Male
6.3 Market Segment by Application
6.3.1 World Recombinant Human Chorionic Gonadotropin Production by Application (2018-2029)
6.3.2 World Recombinant Human Chorionic Gonadotropin Production Value by Application (2018-2029)
6.3.3 World Recombinant Human Chorionic Gonadotropin Average Price by Application (2018-2029)
7 COMPANY PROFILES
7.1 Ferring Pharmaceuticals
7.1.1 Ferring Pharmaceuticals Details
7.1.2 Ferring Pharmaceuticals Major Business
7.1.3 Ferring Pharmaceuticals Recombinant Human Chorionic Gonadotropin Product and Services
7.1.4 Ferring Pharmaceuticals Recombinant Human Chorionic Gonadotropin Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.1.5 Ferring Pharmaceuticals Recent Developments/Updates
7.1.6 Ferring Pharmaceuticals Competitive Strengths & Weaknesses
7.2 Schering Plough
7.2.1 Schering Plough Details
7.2.2 Schering Plough Major Business
7.2.3 Schering Plough Recombinant Human Chorionic Gonadotropin Product and Services
7.2.4 Schering Plough Recombinant Human Chorionic Gonadotropin Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.2.5 Schering Plough Recent Developments/Updates
7.2.6 Schering Plough Competitive Strengths & Weaknesses
7.3 Serum International Ltd
7.3.1 Serum International Ltd Details
7.3.2 Serum International Ltd Major Business
7.3.3 Serum International Ltd Recombinant Human Chorionic Gonadotropin Product and Services
7.3.4 Serum International Ltd Recombinant Human Chorionic Gonadotropin Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.3.5 Serum International Ltd Recent Developments/Updates
7.3.6 Serum International Ltd Competitive Strengths & Weaknesses
7.4 Merck
7.4.1 Merck Details
7.4.2 Merck Major Business
7.4.3 Merck Recombinant Human Chorionic Gonadotropin Product and Services
7.4.4 Merck Recombinant Human Chorionic Gonadotropin Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.4.5 Merck Recent Developments/Updates
7.4.6 Merck Competitive Strengths & Weaknesses
7.5 Wellona Pharma
7.5.1 Wellona Pharma Details
7.5.2 Wellona Pharma Major Business
7.5.3 Wellona Pharma Recombinant Human Chorionic Gonadotropin Product and Services
7.5.4 Wellona Pharma Recombinant Human Chorionic Gonadotropin Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.5.5 Wellona Pharma Recent Developments/Updates
7.5.6 Wellona Pharma Competitive Strengths & Weaknesses
7.6 Bionomics Lifesciences
7.6.1 Bionomics Lifesciences Details
7.6.2 Bionomics Lifesciences Major Business
7.6.3 Bionomics Lifesciences Recombinant Human Chorionic Gonadotropin Product and Services
7.6.4 Bionomics Lifesciences Recombinant Human Chorionic Gonadotropin Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.6.5 Bionomics Lifesciences Recent Developments/Updates
7.6.6 Bionomics Lifesciences Competitive Strengths & Weaknesses
7.7 Marvel Oceanic Private Limited
7.7.1 Marvel Oceanic Private Limited Details
7.7.2 Marvel Oceanic Private Limited Major Business
7.7.3 Marvel Oceanic Private Limited Recombinant Human Chorionic Gonadotropin Product and Services
7.7.4 Marvel Oceanic Private Limited Recombinant Human Chorionic Gonadotropin Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.7.5 Marvel Oceanic Private Limited Recent Developments/Updates
7.7.6 Marvel Oceanic Private Limited Competitive Strengths & Weaknesses
7.8 Facmed Pharmaceuticals
7.8.1 Facmed Pharmaceuticals Details
7.8.2 Facmed Pharmaceuticals Major Business
7.8.3 Facmed Pharmaceuticals Recombinant Human Chorionic Gonadotropin Product and Services
7.8.4 Facmed Pharmaceuticals Recombinant Human Chorionic Gonadotropin Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.8.5 Facmed Pharmaceuticals Recent Developments/Updates
7.8.6 Facmed Pharmaceuticals Competitive Strengths & Weaknesses
8 INDUSTRY CHAIN ANALYSIS
8.1 Recombinant Human Chorionic Gonadotropin Industry Chain
8.2 Recombinant Human Chorionic Gonadotropin Upstream Analysis
8.2.1 Recombinant Human Chorionic Gonadotropin Core Raw Materials
8.2.2 Main Manufacturers of Recombinant Human Chorionic Gonadotropin Core Raw Materials
8.3 Midstream Analysis
8.4 Downstream Analysis
8.5 Recombinant Human Chorionic Gonadotropin Production Mode
8.6 Recombinant Human Chorionic Gonadotropin Procurement Model
8.7 Recombinant Human Chorionic Gonadotropin Industry Sales Model and Sales Channels
8.7.1 Recombinant Human Chorionic Gonadotropin Sales Model
8.7.2 Recombinant Human Chorionic Gonadotropin Typical Customers
9 RESEARCH FINDINGS AND CONCLUSION
10 APPENDIX
10.1 Methodology
10.2 Research Process and Data Source
10.3 Disclaimer
1.1 Recombinant Human Chorionic Gonadotropin Introduction
1.2 World Recombinant Human Chorionic Gonadotropin Supply & Forecast
1.2.1 World Recombinant Human Chorionic Gonadotropin Production Value (2018 & 2022 & 2029)
1.2.2 World Recombinant Human Chorionic Gonadotropin Production (2018-2029)
1.2.3 World Recombinant Human Chorionic Gonadotropin Pricing Trends (2018-2029)
1.3 World Recombinant Human Chorionic Gonadotropin Production by Region (Based on Production Site)
1.3.1 World Recombinant Human Chorionic Gonadotropin Production Value by Region (2018-2029)
1.3.2 World Recombinant Human Chorionic Gonadotropin Production by Region (2018-2029)
1.3.3 World Recombinant Human Chorionic Gonadotropin Average Price by Region (2018-2029)
1.3.4 North America Recombinant Human Chorionic Gonadotropin Production (2018-2029)
1.3.5 Europe Recombinant Human Chorionic Gonadotropin Production (2018-2029)
1.3.6 China Recombinant Human Chorionic Gonadotropin Production (2018-2029)
1.3.7 Japan Recombinant Human Chorionic Gonadotropin Production (2018-2029)
1.4 Market Drivers, Restraints and Trends
1.4.1 Recombinant Human Chorionic Gonadotropin Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 Recombinant Human Chorionic Gonadotropin Major Market Trends
1.5 Influence of COVID-19 and Russia-Ukraine War
1.5.1 Influence of COVID-19
1.5.2 Influence of Russia-Ukraine War
2 DEMAND SUMMARY
2.1 World Recombinant Human Chorionic Gonadotropin Demand (2018-2029)
2.2 World Recombinant Human Chorionic Gonadotropin Consumption by Region
2.2.1 World Recombinant Human Chorionic Gonadotropin Consumption by Region (2018-2023)
2.2.2 World Recombinant Human Chorionic Gonadotropin Consumption Forecast by Region (2024-2029)
2.3 United States Recombinant Human Chorionic Gonadotropin Consumption (2018-2029)
2.4 China Recombinant Human Chorionic Gonadotropin Consumption (2018-2029)
2.5 Europe Recombinant Human Chorionic Gonadotropin Consumption (2018-2029)
2.6 Japan Recombinant Human Chorionic Gonadotropin Consumption (2018-2029)
2.7 South Korea Recombinant Human Chorionic Gonadotropin Consumption (2018-2029)
2.8 ASEAN Recombinant Human Chorionic Gonadotropin Consumption (2018-2029)
2.9 India Recombinant Human Chorionic Gonadotropin Consumption (2018-2029)
3 WORLD RECOMBINANT HUMAN CHORIONIC GONADOTROPIN MANUFACTURERS COMPETITIVE ANALYSIS
3.1 World Recombinant Human Chorionic Gonadotropin Production Value by Manufacturer (2018-2023)
3.2 World Recombinant Human Chorionic Gonadotropin Production by Manufacturer (2018-2023)
3.3 World Recombinant Human Chorionic Gonadotropin Average Price by Manufacturer (2018-2023)
3.4 Recombinant Human Chorionic Gonadotropin Company Evaluation Quadrant
3.5 Industry Rank and Concentration Rate (CR)
3.5.1 Global Recombinant Human Chorionic Gonadotropin Industry Rank of Major Manufacturers
3.5.2 Global Concentration Ratios (CR4) for Recombinant Human Chorionic Gonadotropin in 2022
3.5.3 Global Concentration Ratios (CR8) for Recombinant Human Chorionic Gonadotropin in 2022
3.6 Recombinant Human Chorionic Gonadotropin Market: Overall Company Footprint Analysis
3.6.1 Recombinant Human Chorionic Gonadotropin Market: Region Footprint
3.6.2 Recombinant Human Chorionic Gonadotropin Market: Company Product Type Footprint
3.6.3 Recombinant Human Chorionic Gonadotropin Market: Company Product Application Footprint
3.7 Competitive Environment
3.7.1 Historical Structure of the Industry
3.7.2 Barriers of Market Entry
3.7.3 Factors of Competition
3.8 New Entrant and Capacity Expansion Plans
3.9 Mergers, Acquisition, Agreements, and Collaborations
4 UNITED STATES VS CHINA VS REST OF THE WORLD
4.1 United States VS China: Recombinant Human Chorionic Gonadotropin Production Value Comparison
4.1.1 United States VS China: Recombinant Human Chorionic Gonadotropin Production Value Comparison (2018 & 2022 & 2029)
4.1.2 United States VS China: Recombinant Human Chorionic Gonadotropin Production Value Market Share Comparison (2018 & 2022 & 2029)
4.2 United States VS China: Recombinant Human Chorionic Gonadotropin Production Comparison
4.2.1 United States VS China: Recombinant Human Chorionic Gonadotropin Production Comparison (2018 & 2022 & 2029)
4.2.2 United States VS China: Recombinant Human Chorionic Gonadotropin Production Market Share Comparison (2018 & 2022 & 2029)
4.3 United States VS China: Recombinant Human Chorionic Gonadotropin Consumption Comparison
4.3.1 United States VS China: Recombinant Human Chorionic Gonadotropin Consumption Comparison (2018 & 2022 & 2029)
4.3.2 United States VS China: Recombinant Human Chorionic Gonadotropin Consumption Market Share Comparison (2018 & 2022 & 2029)
4.4 United States Based Recombinant Human Chorionic Gonadotropin Manufacturers and Market Share, 2018-2023
4.4.1 United States Based Recombinant Human Chorionic Gonadotropin Manufacturers, Headquarters and Production Site (States, Country)
4.4.2 United States Based Manufacturers Recombinant Human Chorionic Gonadotropin Production Value (2018-2023)
4.4.3 United States Based Manufacturers Recombinant Human Chorionic Gonadotropin Production (2018-2023)
4.5 China Based Recombinant Human Chorionic Gonadotropin Manufacturers and Market Share
4.5.1 China Based Recombinant Human Chorionic Gonadotropin Manufacturers, Headquarters and Production Site (Province, Country)
4.5.2 China Based Manufacturers Recombinant Human Chorionic Gonadotropin Production Value (2018-2023)
4.5.3 China Based Manufacturers Recombinant Human Chorionic Gonadotropin Production (2018-2023)
4.6 Rest of World Based Recombinant Human Chorionic Gonadotropin Manufacturers and Market Share, 2018-2023
4.6.1 Rest of World Based Recombinant Human Chorionic Gonadotropin Manufacturers, Headquarters and Production Site (State, Country)
4.6.2 Rest of World Based Manufacturers Recombinant Human Chorionic Gonadotropin Production Value (2018-2023)
4.6.3 Rest of World Based Manufacturers Recombinant Human Chorionic Gonadotropin Production (2018-2023)
5 MARKET ANALYSIS BY TYPE
5.1 World Recombinant Human Chorionic Gonadotropin Market Size Overview by Type: 2018 VS 2022 VS 2029
5.2 Segment Introduction by Type
5.2.1 Intramuscular Powder for Injection
5.2.2 Subcutaneous Solution for Injection
5.3 Market Segment by Type
5.3.1 World Recombinant Human Chorionic Gonadotropin Production by Type (2018-2029)
5.3.2 World Recombinant Human Chorionic Gonadotropin Production Value by Type (2018-2029)
5.3.3 World Recombinant Human Chorionic Gonadotropin Average Price by Type (2018-2029)
6 MARKET ANALYSIS BY APPLICATION
6.1 World Recombinant Human Chorionic Gonadotropin Market Size Overview by Application: 2018 VS 2022 VS 2029
6.2 Segment Introduction by Application
6.2.1 Female
6.2.2 Male
6.3 Market Segment by Application
6.3.1 World Recombinant Human Chorionic Gonadotropin Production by Application (2018-2029)
6.3.2 World Recombinant Human Chorionic Gonadotropin Production Value by Application (2018-2029)
6.3.3 World Recombinant Human Chorionic Gonadotropin Average Price by Application (2018-2029)
7 COMPANY PROFILES
7.1 Ferring Pharmaceuticals
7.1.1 Ferring Pharmaceuticals Details
7.1.2 Ferring Pharmaceuticals Major Business
7.1.3 Ferring Pharmaceuticals Recombinant Human Chorionic Gonadotropin Product and Services
7.1.4 Ferring Pharmaceuticals Recombinant Human Chorionic Gonadotropin Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.1.5 Ferring Pharmaceuticals Recent Developments/Updates
7.1.6 Ferring Pharmaceuticals Competitive Strengths & Weaknesses
7.2 Schering Plough
7.2.1 Schering Plough Details
7.2.2 Schering Plough Major Business
7.2.3 Schering Plough Recombinant Human Chorionic Gonadotropin Product and Services
7.2.4 Schering Plough Recombinant Human Chorionic Gonadotropin Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.2.5 Schering Plough Recent Developments/Updates
7.2.6 Schering Plough Competitive Strengths & Weaknesses
7.3 Serum International Ltd
7.3.1 Serum International Ltd Details
7.3.2 Serum International Ltd Major Business
7.3.3 Serum International Ltd Recombinant Human Chorionic Gonadotropin Product and Services
7.3.4 Serum International Ltd Recombinant Human Chorionic Gonadotropin Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.3.5 Serum International Ltd Recent Developments/Updates
7.3.6 Serum International Ltd Competitive Strengths & Weaknesses
7.4 Merck
7.4.1 Merck Details
7.4.2 Merck Major Business
7.4.3 Merck Recombinant Human Chorionic Gonadotropin Product and Services
7.4.4 Merck Recombinant Human Chorionic Gonadotropin Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.4.5 Merck Recent Developments/Updates
7.4.6 Merck Competitive Strengths & Weaknesses
7.5 Wellona Pharma
7.5.1 Wellona Pharma Details
7.5.2 Wellona Pharma Major Business
7.5.3 Wellona Pharma Recombinant Human Chorionic Gonadotropin Product and Services
7.5.4 Wellona Pharma Recombinant Human Chorionic Gonadotropin Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.5.5 Wellona Pharma Recent Developments/Updates
7.5.6 Wellona Pharma Competitive Strengths & Weaknesses
7.6 Bionomics Lifesciences
7.6.1 Bionomics Lifesciences Details
7.6.2 Bionomics Lifesciences Major Business
7.6.3 Bionomics Lifesciences Recombinant Human Chorionic Gonadotropin Product and Services
7.6.4 Bionomics Lifesciences Recombinant Human Chorionic Gonadotropin Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.6.5 Bionomics Lifesciences Recent Developments/Updates
7.6.6 Bionomics Lifesciences Competitive Strengths & Weaknesses
7.7 Marvel Oceanic Private Limited
7.7.1 Marvel Oceanic Private Limited Details
7.7.2 Marvel Oceanic Private Limited Major Business
7.7.3 Marvel Oceanic Private Limited Recombinant Human Chorionic Gonadotropin Product and Services
7.7.4 Marvel Oceanic Private Limited Recombinant Human Chorionic Gonadotropin Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.7.5 Marvel Oceanic Private Limited Recent Developments/Updates
7.7.6 Marvel Oceanic Private Limited Competitive Strengths & Weaknesses
7.8 Facmed Pharmaceuticals
7.8.1 Facmed Pharmaceuticals Details
7.8.2 Facmed Pharmaceuticals Major Business
7.8.3 Facmed Pharmaceuticals Recombinant Human Chorionic Gonadotropin Product and Services
7.8.4 Facmed Pharmaceuticals Recombinant Human Chorionic Gonadotropin Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.8.5 Facmed Pharmaceuticals Recent Developments/Updates
7.8.6 Facmed Pharmaceuticals Competitive Strengths & Weaknesses
8 INDUSTRY CHAIN ANALYSIS
8.1 Recombinant Human Chorionic Gonadotropin Industry Chain
8.2 Recombinant Human Chorionic Gonadotropin Upstream Analysis
8.2.1 Recombinant Human Chorionic Gonadotropin Core Raw Materials
8.2.2 Main Manufacturers of Recombinant Human Chorionic Gonadotropin Core Raw Materials
8.3 Midstream Analysis
8.4 Downstream Analysis
8.5 Recombinant Human Chorionic Gonadotropin Production Mode
8.6 Recombinant Human Chorionic Gonadotropin Procurement Model
8.7 Recombinant Human Chorionic Gonadotropin Industry Sales Model and Sales Channels
8.7.1 Recombinant Human Chorionic Gonadotropin Sales Model
8.7.2 Recombinant Human Chorionic Gonadotropin Typical Customers
9 RESEARCH FINDINGS AND CONCLUSION
10 APPENDIX
10.1 Methodology
10.2 Research Process and Data Source
10.3 Disclaimer
LIST OF TABLES
Table 1. World Recombinant Human Chorionic Gonadotropin Production Value by Region (2018, 2022 and 2029) & (USD Million)
Table 2. World Recombinant Human Chorionic Gonadotropin Production Value by Region (2018-2023) & (USD Million)
Table 3. World Recombinant Human Chorionic Gonadotropin Production Value by Region (2024-2029) & (USD Million)
Table 4. World Recombinant Human Chorionic Gonadotropin Production Value Market Share by Region (2018-2023)
Table 5. World Recombinant Human Chorionic Gonadotropin Production Value Market Share by Region (2024-2029)
Table 6. World Recombinant Human Chorionic Gonadotropin Production by Region (2018-2023) & (K Units)
Table 7. World Recombinant Human Chorionic Gonadotropin Production by Region (2024-2029) & (K Units)
Table 8. World Recombinant Human Chorionic Gonadotropin Production Market Share by Region (2018-2023)
Table 9. World Recombinant Human Chorionic Gonadotropin Production Market Share by Region (2024-2029)
Table 10. World Recombinant Human Chorionic Gonadotropin Average Price by Region (2018-2023) & (US$/Unit)
Table 11. World Recombinant Human Chorionic Gonadotropin Average Price by Region (2024-2029) & (US$/Unit)
Table 12. Recombinant Human Chorionic Gonadotropin Major Market Trends
Table 13. World Recombinant Human Chorionic Gonadotropin Consumption Growth Rate Forecast by Region (2018 & 2022 & 2029) & (K Units)
Table 14. World Recombinant Human Chorionic Gonadotropin Consumption by Region (2018-2023) & (K Units)
Table 15. World Recombinant Human Chorionic Gonadotropin Consumption Forecast by Region (2024-2029) & (K Units)
Table 16. World Recombinant Human Chorionic Gonadotropin Production Value by Manufacturer (2018-2023) & (USD Million)
Table 17. Production Value Market Share of Key Recombinant Human Chorionic Gonadotropin Producers in 2022
Table 18. World Recombinant Human Chorionic Gonadotropin Production by Manufacturer (2018-2023) & (K Units)
Table 19. Production Market Share of Key Recombinant Human Chorionic Gonadotropin Producers in 2022
Table 20. World Recombinant Human Chorionic Gonadotropin Average Price by Manufacturer (2018-2023) & (US$/Unit)
Table 21. Global Recombinant Human Chorionic Gonadotropin Company Evaluation Quadrant
Table 22. World Recombinant Human Chorionic Gonadotropin Industry Rank of Major Manufacturers, Based on Production Value in 2022
Table 23. Head Office and Recombinant Human Chorionic Gonadotropin Production Site of Key Manufacturer
Table 24. Recombinant Human Chorionic Gonadotropin Market: Company Product Type Footprint
Table 25. Recombinant Human Chorionic Gonadotropin Market: Company Product Application Footprint
Table 26. Recombinant Human Chorionic Gonadotropin Competitive Factors
Table 27. Recombinant Human Chorionic Gonadotropin New Entrant and Capacity Expansion Plans
Table 28. Recombinant Human Chorionic Gonadotropin Mergers & Acquisitions Activity
Table 29. United States VS China Recombinant Human Chorionic Gonadotropin Production Value Comparison, (2018 & 2022 & 2029) & (USD Million)
Table 30. United States VS China Recombinant Human Chorionic Gonadotropin Production Comparison, (2018 & 2022 & 2029) & (K Units)
Table 31. United States VS China Recombinant Human Chorionic Gonadotropin Consumption Comparison, (2018 & 2022 & 2029) & (K Units)
Table 32. United States Based Recombinant Human Chorionic Gonadotropin Manufacturers, Headquarters and Production Site (States, Country)
Table 33. United States Based Manufacturers Recombinant Human Chorionic Gonadotropin Production Value, (2018-2023) & (USD Million)
Table 34. United States Based Manufacturers Recombinant Human Chorionic Gonadotropin Production Value Market Share (2018-2023)
Table 35. United States Based Manufacturers Recombinant Human Chorionic Gonadotropin Production (2018-2023) & (K Units)
Table 36. United States Based Manufacturers Recombinant Human Chorionic Gonadotropin Production Market Share (2018-2023)
Table 37. China Based Recombinant Human Chorionic Gonadotropin Manufacturers, Headquarters and Production Site (Province, Country)
Table 38. China Based Manufacturers Recombinant Human Chorionic Gonadotropin Production Value, (2018-2023) & (USD Million)
Table 39. China Based Manufacturers Recombinant Human Chorionic Gonadotropin Production Value Market Share (2018-2023)
Table 40. China Based Manufacturers Recombinant Human Chorionic Gonadotropin Production (2018-2023) & (K Units)
Table 41. China Based Manufacturers Recombinant Human Chorionic Gonadotropin Production Market Share (2018-2023)
Table 42. Rest of World Based Recombinant Human Chorionic Gonadotropin Manufacturers, Headquarters and Production Site (States, Country)
Table 43. Rest of World Based Manufacturers Recombinant Human Chorionic Gonadotropin Production Value, (2018-2023) & (USD Million)
Table 44. Rest of World Based Manufacturers Recombinant Human Chorionic Gonadotropin Production Value Market Share (2018-2023)
Table 45. Rest of World Based Manufacturers Recombinant Human Chorionic Gonadotropin Production (2018-2023) & (K Units)
Table 46. Rest of World Based Manufacturers Recombinant Human Chorionic Gonadotropin Production Market Share (2018-2023)
Table 47. World Recombinant Human Chorionic Gonadotropin Production Value by Type, (USD Million), 2018 & 2022 & 2029
Table 48. World Recombinant Human Chorionic Gonadotropin Production by Type (2018-2023) & (K Units)
Table 49. World Recombinant Human Chorionic Gonadotropin Production by Type (2024-2029) & (K Units)
Table 50. World Recombinant Human Chorionic Gonadotropin Production Value by Type (2018-2023) & (USD Million)
Table 51. World Recombinant Human Chorionic Gonadotropin Production Value by Type (2024-2029) & (USD Million)
Table 52. World Recombinant Human Chorionic Gonadotropin Average Price by Type (2018-2023) & (US$/Unit)
Table 53. World Recombinant Human Chorionic Gonadotropin Average Price by Type (2024-2029) & (US$/Unit)
Table 54. World Recombinant Human Chorionic Gonadotropin Production Value by Application, (USD Million), 2018 & 2022 & 2029
Table 55. World Recombinant Human Chorionic Gonadotropin Production by Application (2018-2023) & (K Units)
Table 56. World Recombinant Human Chorionic Gonadotropin Production by Application (2024-2029) & (K Units)
Table 57. World Recombinant Human Chorionic Gonadotropin Production Value by Application (2018-2023) & (USD Million)
Table 58. World Recombinant Human Chorionic Gonadotropin Production Value by Application (2024-2029) & (USD Million)
Table 59. World Recombinant Human Chorionic Gonadotropin Average Price by Application (2018-2023) & (US$/Unit)
Table 60. World Recombinant Human Chorionic Gonadotropin Average Price by Application (2024-2029) & (US$/Unit)
Table 61. Ferring Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 62. Ferring Pharmaceuticals Major Business
Table 63. Ferring Pharmaceuticals Recombinant Human Chorionic Gonadotropin Product and Services
Table 64. Ferring Pharmaceuticals Recombinant Human Chorionic Gonadotropin Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 65. Ferring Pharmaceuticals Recent Developments/Updates
Table 66. Ferring Pharmaceuticals Competitive Strengths & Weaknesses
Table 67. Schering Plough Basic Information, Manufacturing Base and Competitors
Table 68. Schering Plough Major Business
Table 69. Schering Plough Recombinant Human Chorionic Gonadotropin Product and Services
Table 70. Schering Plough Recombinant Human Chorionic Gonadotropin Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 71. Schering Plough Recent Developments/Updates
Table 72. Schering Plough Competitive Strengths & Weaknesses
Table 73. Serum International Ltd Basic Information, Manufacturing Base and Competitors
Table 74. Serum International Ltd Major Business
Table 75. Serum International Ltd Recombinant Human Chorionic Gonadotropin Product and Services
Table 76. Serum International Ltd Recombinant Human Chorionic Gonadotropin Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 77. Serum International Ltd Recent Developments/Updates
Table 78. Serum International Ltd Competitive Strengths & Weaknesses
Table 79. Merck Basic Information, Manufacturing Base and Competitors
Table 80. Merck Major Business
Table 81. Merck Recombinant Human Chorionic Gonadotropin Product and Services
Table 82. Merck Recombinant Human Chorionic Gonadotropin Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 83. Merck Recent Developments/Updates
Table 84. Merck Competitive Strengths & Weaknesses
Table 85. Wellona Pharma Basic Information, Manufacturing Base and Competitors
Table 86. Wellona Pharma Major Business
Table 87. Wellona Pharma Recombinant Human Chorionic Gonadotropin Product and Services
Table 88. Wellona Pharma Recombinant Human Chorionic Gonadotropin Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 89. Wellona Pharma Recent Developments/Updates
Table 90. Wellona Pharma Competitive Strengths & Weaknesses
Table 91. Bionomics Lifesciences Basic Information, Manufacturing Base and Competitors
Table 92. Bionomics Lifesciences Major Business
Table 93. Bionomics Lifesciences Recombinant Human Chorionic Gonadotropin Product and Services
Table 94. Bionomics Lifesciences Recombinant Human Chorionic Gonadotropin Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 95. Bionomics Lifesciences Recent Developments/Updates
Table 96. Bionomics Lifesciences Competitive Strengths & Weaknesses
Table 97. Marvel Oceanic Private Limited Basic Information, Manufacturing Base and Competitors
Table 98. Marvel Oceanic Private Limited Major Business
Table 99. Marvel Oceanic Private Limited Recombinant Human Chorionic Gonadotropin Product and Services
Table 100. Marvel Oceanic Private Limited Recombinant Human Chorionic Gonadotropin Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 101. Marvel Oceanic Private Limited Recent Developments/Updates
Table 102. Facmed Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 103. Facmed Pharmaceuticals Major Business
Table 104. Facmed Pharmaceuticals Recombinant Human Chorionic Gonadotropin Product and Services
Table 105. Facmed Pharmaceuticals Recombinant Human Chorionic Gonadotropin Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 106. Global Key Players of Recombinant Human Chorionic Gonadotropin Upstream (Raw Materials)
Table 107. Recombinant Human Chorionic Gonadotropin Typical Customers
Table 108. Recombinant Human Chorionic Gonadotropin Typical Distributors
Table 1. World Recombinant Human Chorionic Gonadotropin Production Value by Region (2018, 2022 and 2029) & (USD Million)
Table 2. World Recombinant Human Chorionic Gonadotropin Production Value by Region (2018-2023) & (USD Million)
Table 3. World Recombinant Human Chorionic Gonadotropin Production Value by Region (2024-2029) & (USD Million)
Table 4. World Recombinant Human Chorionic Gonadotropin Production Value Market Share by Region (2018-2023)
Table 5. World Recombinant Human Chorionic Gonadotropin Production Value Market Share by Region (2024-2029)
Table 6. World Recombinant Human Chorionic Gonadotropin Production by Region (2018-2023) & (K Units)
Table 7. World Recombinant Human Chorionic Gonadotropin Production by Region (2024-2029) & (K Units)
Table 8. World Recombinant Human Chorionic Gonadotropin Production Market Share by Region (2018-2023)
Table 9. World Recombinant Human Chorionic Gonadotropin Production Market Share by Region (2024-2029)
Table 10. World Recombinant Human Chorionic Gonadotropin Average Price by Region (2018-2023) & (US$/Unit)
Table 11. World Recombinant Human Chorionic Gonadotropin Average Price by Region (2024-2029) & (US$/Unit)
Table 12. Recombinant Human Chorionic Gonadotropin Major Market Trends
Table 13. World Recombinant Human Chorionic Gonadotropin Consumption Growth Rate Forecast by Region (2018 & 2022 & 2029) & (K Units)
Table 14. World Recombinant Human Chorionic Gonadotropin Consumption by Region (2018-2023) & (K Units)
Table 15. World Recombinant Human Chorionic Gonadotropin Consumption Forecast by Region (2024-2029) & (K Units)
Table 16. World Recombinant Human Chorionic Gonadotropin Production Value by Manufacturer (2018-2023) & (USD Million)
Table 17. Production Value Market Share of Key Recombinant Human Chorionic Gonadotropin Producers in 2022
Table 18. World Recombinant Human Chorionic Gonadotropin Production by Manufacturer (2018-2023) & (K Units)
Table 19. Production Market Share of Key Recombinant Human Chorionic Gonadotropin Producers in 2022
Table 20. World Recombinant Human Chorionic Gonadotropin Average Price by Manufacturer (2018-2023) & (US$/Unit)
Table 21. Global Recombinant Human Chorionic Gonadotropin Company Evaluation Quadrant
Table 22. World Recombinant Human Chorionic Gonadotropin Industry Rank of Major Manufacturers, Based on Production Value in 2022
Table 23. Head Office and Recombinant Human Chorionic Gonadotropin Production Site of Key Manufacturer
Table 24. Recombinant Human Chorionic Gonadotropin Market: Company Product Type Footprint
Table 25. Recombinant Human Chorionic Gonadotropin Market: Company Product Application Footprint
Table 26. Recombinant Human Chorionic Gonadotropin Competitive Factors
Table 27. Recombinant Human Chorionic Gonadotropin New Entrant and Capacity Expansion Plans
Table 28. Recombinant Human Chorionic Gonadotropin Mergers & Acquisitions Activity
Table 29. United States VS China Recombinant Human Chorionic Gonadotropin Production Value Comparison, (2018 & 2022 & 2029) & (USD Million)
Table 30. United States VS China Recombinant Human Chorionic Gonadotropin Production Comparison, (2018 & 2022 & 2029) & (K Units)
Table 31. United States VS China Recombinant Human Chorionic Gonadotropin Consumption Comparison, (2018 & 2022 & 2029) & (K Units)
Table 32. United States Based Recombinant Human Chorionic Gonadotropin Manufacturers, Headquarters and Production Site (States, Country)
Table 33. United States Based Manufacturers Recombinant Human Chorionic Gonadotropin Production Value, (2018-2023) & (USD Million)
Table 34. United States Based Manufacturers Recombinant Human Chorionic Gonadotropin Production Value Market Share (2018-2023)
Table 35. United States Based Manufacturers Recombinant Human Chorionic Gonadotropin Production (2018-2023) & (K Units)
Table 36. United States Based Manufacturers Recombinant Human Chorionic Gonadotropin Production Market Share (2018-2023)
Table 37. China Based Recombinant Human Chorionic Gonadotropin Manufacturers, Headquarters and Production Site (Province, Country)
Table 38. China Based Manufacturers Recombinant Human Chorionic Gonadotropin Production Value, (2018-2023) & (USD Million)
Table 39. China Based Manufacturers Recombinant Human Chorionic Gonadotropin Production Value Market Share (2018-2023)
Table 40. China Based Manufacturers Recombinant Human Chorionic Gonadotropin Production (2018-2023) & (K Units)
Table 41. China Based Manufacturers Recombinant Human Chorionic Gonadotropin Production Market Share (2018-2023)
Table 42. Rest of World Based Recombinant Human Chorionic Gonadotropin Manufacturers, Headquarters and Production Site (States, Country)
Table 43. Rest of World Based Manufacturers Recombinant Human Chorionic Gonadotropin Production Value, (2018-2023) & (USD Million)
Table 44. Rest of World Based Manufacturers Recombinant Human Chorionic Gonadotropin Production Value Market Share (2018-2023)
Table 45. Rest of World Based Manufacturers Recombinant Human Chorionic Gonadotropin Production (2018-2023) & (K Units)
Table 46. Rest of World Based Manufacturers Recombinant Human Chorionic Gonadotropin Production Market Share (2018-2023)
Table 47. World Recombinant Human Chorionic Gonadotropin Production Value by Type, (USD Million), 2018 & 2022 & 2029
Table 48. World Recombinant Human Chorionic Gonadotropin Production by Type (2018-2023) & (K Units)
Table 49. World Recombinant Human Chorionic Gonadotropin Production by Type (2024-2029) & (K Units)
Table 50. World Recombinant Human Chorionic Gonadotropin Production Value by Type (2018-2023) & (USD Million)
Table 51. World Recombinant Human Chorionic Gonadotropin Production Value by Type (2024-2029) & (USD Million)
Table 52. World Recombinant Human Chorionic Gonadotropin Average Price by Type (2018-2023) & (US$/Unit)
Table 53. World Recombinant Human Chorionic Gonadotropin Average Price by Type (2024-2029) & (US$/Unit)
Table 54. World Recombinant Human Chorionic Gonadotropin Production Value by Application, (USD Million), 2018 & 2022 & 2029
Table 55. World Recombinant Human Chorionic Gonadotropin Production by Application (2018-2023) & (K Units)
Table 56. World Recombinant Human Chorionic Gonadotropin Production by Application (2024-2029) & (K Units)
Table 57. World Recombinant Human Chorionic Gonadotropin Production Value by Application (2018-2023) & (USD Million)
Table 58. World Recombinant Human Chorionic Gonadotropin Production Value by Application (2024-2029) & (USD Million)
Table 59. World Recombinant Human Chorionic Gonadotropin Average Price by Application (2018-2023) & (US$/Unit)
Table 60. World Recombinant Human Chorionic Gonadotropin Average Price by Application (2024-2029) & (US$/Unit)
Table 61. Ferring Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 62. Ferring Pharmaceuticals Major Business
Table 63. Ferring Pharmaceuticals Recombinant Human Chorionic Gonadotropin Product and Services
Table 64. Ferring Pharmaceuticals Recombinant Human Chorionic Gonadotropin Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 65. Ferring Pharmaceuticals Recent Developments/Updates
Table 66. Ferring Pharmaceuticals Competitive Strengths & Weaknesses
Table 67. Schering Plough Basic Information, Manufacturing Base and Competitors
Table 68. Schering Plough Major Business
Table 69. Schering Plough Recombinant Human Chorionic Gonadotropin Product and Services
Table 70. Schering Plough Recombinant Human Chorionic Gonadotropin Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 71. Schering Plough Recent Developments/Updates
Table 72. Schering Plough Competitive Strengths & Weaknesses
Table 73. Serum International Ltd Basic Information, Manufacturing Base and Competitors
Table 74. Serum International Ltd Major Business
Table 75. Serum International Ltd Recombinant Human Chorionic Gonadotropin Product and Services
Table 76. Serum International Ltd Recombinant Human Chorionic Gonadotropin Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 77. Serum International Ltd Recent Developments/Updates
Table 78. Serum International Ltd Competitive Strengths & Weaknesses
Table 79. Merck Basic Information, Manufacturing Base and Competitors
Table 80. Merck Major Business
Table 81. Merck Recombinant Human Chorionic Gonadotropin Product and Services
Table 82. Merck Recombinant Human Chorionic Gonadotropin Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 83. Merck Recent Developments/Updates
Table 84. Merck Competitive Strengths & Weaknesses
Table 85. Wellona Pharma Basic Information, Manufacturing Base and Competitors
Table 86. Wellona Pharma Major Business
Table 87. Wellona Pharma Recombinant Human Chorionic Gonadotropin Product and Services
Table 88. Wellona Pharma Recombinant Human Chorionic Gonadotropin Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 89. Wellona Pharma Recent Developments/Updates
Table 90. Wellona Pharma Competitive Strengths & Weaknesses
Table 91. Bionomics Lifesciences Basic Information, Manufacturing Base and Competitors
Table 92. Bionomics Lifesciences Major Business
Table 93. Bionomics Lifesciences Recombinant Human Chorionic Gonadotropin Product and Services
Table 94. Bionomics Lifesciences Recombinant Human Chorionic Gonadotropin Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 95. Bionomics Lifesciences Recent Developments/Updates
Table 96. Bionomics Lifesciences Competitive Strengths & Weaknesses
Table 97. Marvel Oceanic Private Limited Basic Information, Manufacturing Base and Competitors
Table 98. Marvel Oceanic Private Limited Major Business
Table 99. Marvel Oceanic Private Limited Recombinant Human Chorionic Gonadotropin Product and Services
Table 100. Marvel Oceanic Private Limited Recombinant Human Chorionic Gonadotropin Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 101. Marvel Oceanic Private Limited Recent Developments/Updates
Table 102. Facmed Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 103. Facmed Pharmaceuticals Major Business
Table 104. Facmed Pharmaceuticals Recombinant Human Chorionic Gonadotropin Product and Services
Table 105. Facmed Pharmaceuticals Recombinant Human Chorionic Gonadotropin Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 106. Global Key Players of Recombinant Human Chorionic Gonadotropin Upstream (Raw Materials)
Table 107. Recombinant Human Chorionic Gonadotropin Typical Customers
Table 108. Recombinant Human Chorionic Gonadotropin Typical Distributors
LIST OF FIGURES
Figure 1. Recombinant Human Chorionic Gonadotropin Picture
Figure 2. World Recombinant Human Chorionic Gonadotropin Production Value: 2018 & 2022 & 2029, (USD Million)
Figure 3. World Recombinant Human Chorionic Gonadotropin Production Value and Forecast (2018-2029) & (USD Million)
Figure 4. World Recombinant Human Chorionic Gonadotropin Production (2018-2029) & (K Units)
Figure 5. World Recombinant Human Chorionic Gonadotropin Average Price (2018-2029) & (US$/Unit)
Figure 6. World Recombinant Human Chorionic Gonadotropin Production Value Market Share by Region (2018-2029)
Figure 7. World Recombinant Human Chorionic Gonadotropin Production Market Share by Region (2018-2029)
Figure 8. North America Recombinant Human Chorionic Gonadotropin Production (2018-2029) & (K Units)
Figure 9. Europe Recombinant Human Chorionic Gonadotropin Production (2018-2029) & (K Units)
Figure 10. China Recombinant Human Chorionic Gonadotropin Production (2018-2029) & (K Units)
Figure 11. Japan Recombinant Human Chorionic Gonadotropin Production (2018-2029) & (K Units)
Figure 12. Recombinant Human Chorionic Gonadotropin Market Drivers
Figure 13. Factors Affecting Demand
Figure 14. World Recombinant Human Chorionic Gonadotropin Consumption (2018-2029) & (K Units)
Figure 15. World Recombinant Human Chorionic Gonadotropin Consumption Market Share by Region (2018-2029)
Figure 16. United States Recombinant Human Chorionic Gonadotropin Consumption (2018-2029) & (K Units)
Figure 17. China Recombinant Human Chorionic Gonadotropin Consumption (2018-2029) & (K Units)
Figure 18. Europe Recombinant Human Chorionic Gonadotropin Consumption (2018-2029) & (K Units)
Figure 19. Japan Recombinant Human Chorionic Gonadotropin Consumption (2018-2029) & (K Units)
Figure 20. South Korea Recombinant Human Chorionic Gonadotropin Consumption (2018-2029) & (K Units)
Figure 21. ASEAN Recombinant Human Chorionic Gonadotropin Consumption (2018-2029) & (K Units)
Figure 22. India Recombinant Human Chorionic Gonadotropin Consumption (2018-2029) & (K Units)
Figure 23. Producer Shipments of Recombinant Human Chorionic Gonadotropin by Manufacturer Revenue ($MM) and Market Share (%): 2022
Figure 24. Global Four-firm Concentration Ratios (CR4) for Recombinant Human Chorionic Gonadotropin Markets in 2022
Figure 25. Global Four-firm Concentration Ratios (CR8) for Recombinant Human Chorionic Gonadotropin Markets in 2022
Figure 26. United States VS China: Recombinant Human Chorionic Gonadotropin Production Value Market Share Comparison (2018 & 2022 & 2029)
Figure 27. United States VS China: Recombinant Human Chorionic Gonadotropin Production Market Share Comparison (2018 & 2022 & 2029)
Figure 28. United States VS China: Recombinant Human Chorionic Gonadotropin Consumption Market Share Comparison (2018 & 2022 & 2029)
Figure 29. United States Based Manufacturers Recombinant Human Chorionic Gonadotropin Production Market Share 2022
Figure 30. China Based Manufacturers Recombinant Human Chorionic Gonadotropin Production Market Share 2022
Figure 31. Rest of World Based Manufacturers Recombinant Human Chorionic Gonadotropin Production Market Share 2022
Figure 32. World Recombinant Human Chorionic Gonadotropin Production Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 33. World Recombinant Human Chorionic Gonadotropin Production Value Market Share by Type in 2022
Figure 34. Intramuscular Powder for Injection
Figure 35. Subcutaneous Solution for Injection
Figure 36. World Recombinant Human Chorionic Gonadotropin Production Market Share by Type (2018-2029)
Figure 37. World Recombinant Human Chorionic Gonadotropin Production Value Market Share by Type (2018-2029)
Figure 38. World Recombinant Human Chorionic Gonadotropin Average Price by Type (2018-2029) & (US$/Unit)
Figure 39. World Recombinant Human Chorionic Gonadotropin Production Value by Application, (USD Million), 2018 & 2022 & 2029
Figure 40. World Recombinant Human Chorionic Gonadotropin Production Value Market Share by Application in 2022
Figure 41. Female
Figure 42. Male
Figure 43. World Recombinant Human Chorionic Gonadotropin Production Market Share by Application (2018-2029)
Figure 44. World Recombinant Human Chorionic Gonadotropin Production Value Market Share by Application (2018-2029)
Figure 45. World Recombinant Human Chorionic Gonadotropin Average Price by Application (2018-2029) & (US$/Unit)
Figure 46. Recombinant Human Chorionic Gonadotropin Industry Chain
Figure 47. Recombinant Human Chorionic Gonadotropin Procurement Model
Figure 48. Recombinant Human Chorionic Gonadotropin Sales Model
Figure 49. Recombinant Human Chorionic Gonadotropin Sales Channels, Direct Sales, and Distribution
Figure 50. Methodology
Figure 51. Research Process and Data Source
Figure 1. Recombinant Human Chorionic Gonadotropin Picture
Figure 2. World Recombinant Human Chorionic Gonadotropin Production Value: 2018 & 2022 & 2029, (USD Million)
Figure 3. World Recombinant Human Chorionic Gonadotropin Production Value and Forecast (2018-2029) & (USD Million)
Figure 4. World Recombinant Human Chorionic Gonadotropin Production (2018-2029) & (K Units)
Figure 5. World Recombinant Human Chorionic Gonadotropin Average Price (2018-2029) & (US$/Unit)
Figure 6. World Recombinant Human Chorionic Gonadotropin Production Value Market Share by Region (2018-2029)
Figure 7. World Recombinant Human Chorionic Gonadotropin Production Market Share by Region (2018-2029)
Figure 8. North America Recombinant Human Chorionic Gonadotropin Production (2018-2029) & (K Units)
Figure 9. Europe Recombinant Human Chorionic Gonadotropin Production (2018-2029) & (K Units)
Figure 10. China Recombinant Human Chorionic Gonadotropin Production (2018-2029) & (K Units)
Figure 11. Japan Recombinant Human Chorionic Gonadotropin Production (2018-2029) & (K Units)
Figure 12. Recombinant Human Chorionic Gonadotropin Market Drivers
Figure 13. Factors Affecting Demand
Figure 14. World Recombinant Human Chorionic Gonadotropin Consumption (2018-2029) & (K Units)
Figure 15. World Recombinant Human Chorionic Gonadotropin Consumption Market Share by Region (2018-2029)
Figure 16. United States Recombinant Human Chorionic Gonadotropin Consumption (2018-2029) & (K Units)
Figure 17. China Recombinant Human Chorionic Gonadotropin Consumption (2018-2029) & (K Units)
Figure 18. Europe Recombinant Human Chorionic Gonadotropin Consumption (2018-2029) & (K Units)
Figure 19. Japan Recombinant Human Chorionic Gonadotropin Consumption (2018-2029) & (K Units)
Figure 20. South Korea Recombinant Human Chorionic Gonadotropin Consumption (2018-2029) & (K Units)
Figure 21. ASEAN Recombinant Human Chorionic Gonadotropin Consumption (2018-2029) & (K Units)
Figure 22. India Recombinant Human Chorionic Gonadotropin Consumption (2018-2029) & (K Units)
Figure 23. Producer Shipments of Recombinant Human Chorionic Gonadotropin by Manufacturer Revenue ($MM) and Market Share (%): 2022
Figure 24. Global Four-firm Concentration Ratios (CR4) for Recombinant Human Chorionic Gonadotropin Markets in 2022
Figure 25. Global Four-firm Concentration Ratios (CR8) for Recombinant Human Chorionic Gonadotropin Markets in 2022
Figure 26. United States VS China: Recombinant Human Chorionic Gonadotropin Production Value Market Share Comparison (2018 & 2022 & 2029)
Figure 27. United States VS China: Recombinant Human Chorionic Gonadotropin Production Market Share Comparison (2018 & 2022 & 2029)
Figure 28. United States VS China: Recombinant Human Chorionic Gonadotropin Consumption Market Share Comparison (2018 & 2022 & 2029)
Figure 29. United States Based Manufacturers Recombinant Human Chorionic Gonadotropin Production Market Share 2022
Figure 30. China Based Manufacturers Recombinant Human Chorionic Gonadotropin Production Market Share 2022
Figure 31. Rest of World Based Manufacturers Recombinant Human Chorionic Gonadotropin Production Market Share 2022
Figure 32. World Recombinant Human Chorionic Gonadotropin Production Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 33. World Recombinant Human Chorionic Gonadotropin Production Value Market Share by Type in 2022
Figure 34. Intramuscular Powder for Injection
Figure 35. Subcutaneous Solution for Injection
Figure 36. World Recombinant Human Chorionic Gonadotropin Production Market Share by Type (2018-2029)
Figure 37. World Recombinant Human Chorionic Gonadotropin Production Value Market Share by Type (2018-2029)
Figure 38. World Recombinant Human Chorionic Gonadotropin Average Price by Type (2018-2029) & (US$/Unit)
Figure 39. World Recombinant Human Chorionic Gonadotropin Production Value by Application, (USD Million), 2018 & 2022 & 2029
Figure 40. World Recombinant Human Chorionic Gonadotropin Production Value Market Share by Application in 2022
Figure 41. Female
Figure 42. Male
Figure 43. World Recombinant Human Chorionic Gonadotropin Production Market Share by Application (2018-2029)
Figure 44. World Recombinant Human Chorionic Gonadotropin Production Value Market Share by Application (2018-2029)
Figure 45. World Recombinant Human Chorionic Gonadotropin Average Price by Application (2018-2029) & (US$/Unit)
Figure 46. Recombinant Human Chorionic Gonadotropin Industry Chain
Figure 47. Recombinant Human Chorionic Gonadotropin Procurement Model
Figure 48. Recombinant Human Chorionic Gonadotropin Sales Model
Figure 49. Recombinant Human Chorionic Gonadotropin Sales Channels, Direct Sales, and Distribution
Figure 50. Methodology
Figure 51. Research Process and Data Source
